Indicaton

TEPADINA® 15mg/vial (thiotepa) is indicated as conditioning treatment prior to haematopoietic progenitor cell transplantation in haematological diseases and solid tumours.

Therapeutic indications
Type of product
Table
  • Phase
    Marketed
  • Available in
    EU, US, SWITZERLAND, GB, CANADA, ISRAEL, RUSSIA, HONG KONG, ARGENTINA, COLOMBIA